|
3140
|
Arbidol hydrochloride
|
Broad-spectrum antiviral agent |
€60.00 |
|
3131
|
Benidipine hydrochloride
|
Ca2+ channel blocker |
€70.00 |
|
2931
|
BRD0705
|
First-in-class, paralog selective GSK3α inhibitor |
€210.00 |
|
3153
|
BRD5648
|
Negative control compound of BRD0705 as a GSK3α inhibitor |
€210.00 |
|
3097
|
DBPR211
|
Potent and selective peripherally restricted CB1 antagonist/inverse agonist |
€125.00 |
|
3135
|
Favipiravir
|
Potent and selective inhibitor of viral RNA polymerase |
€70.00 |
|
3027
|
FEN1 inhibitor 1
|
Potent flap endonuclease-1 (FEN1) inhibitor |
€135.00 |
|
3003
|
HX600
|
RXR-Nurr1 heterodimer complex agonist |
€150.00 |
|
3107
|
Imiquimod
|
TLR7/TLR8 agonist |
€60.00 |
|
3098
|
ME-401
|
Potent, selective and orally available PI3K inhibitor (p110 δ specific) |
€100.00 |
|
3080
|
NCGC00249987
|
Specific, allosteric EYA2 phosphatase inhibitor |
€130.00 |
|
2940
|
Neryl pyrophosphate ammonium salt
|
Monoterpene synthase substrate |
€250.00 |
|
3031
|
NIC3
|
Inhibitor of nucleus accumbens-associated protein-1 (NAC1) homodimerization |
€90.00 |
|
3154
|
rac-BRD0705
|
GSK3α inhibitor |
€140.00 |
|
3139
|
Ritonavir
|
HIV-1 protease inhibitor |
€50.00 |
|
3111
|
Ticagrelor
|
Selective, reversible and orally available P2Y12 antagonist |
€60.00 |
|
3106
|
Valsartan
|
Potent, highly selective, and orally active AT1 antagonist |
€76.00 |
|
3068
|
WEHI-9625
|
First-in-class, potent, and selective mBAK-mediated apoptosis inhibitor |
€150.00 |